Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Adherence and quality of life in adults and children during 3-years of SLIT treatment with Grazax-a real life study.

Kiotseridis H, Arvidsson P, Backer V, Braendholt V, Tunsäter A.

NPJ Prim Care Respir Med. 2018 Feb 12;28(1):4. doi: 10.1038/s41533-018-0072-z.

2.

The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.

Emminger W, Hernández MD, Cardona V, Smeenk F, Fogh BS, Calderon MA, de Blay F, Backer V.

Int Arch Allergy Immunol. 2017;174(1):35-44. doi: 10.1159/000478699. Epub 2017 Sep 27.

3.

Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report.

Pajno GB, Bernardini R, Peroni D, Arasi S, Martelli A, Landi M, Passalacqua G, Muraro A, La Grutta S, Fiocchi A, Indinnimeo L, Caffarelli C, Calamelli E, Comberiati P, Duse M; Allergen-specific Immunotherapy panel of the Italian Society of Pediatric Allergy and Immunology (SIAIP).

Ital J Pediatr. 2017 Jan 23;43(1):13. doi: 10.1186/s13052-016-0315-y. Review.

4.

Intradermal grass pollen immunotherapy increases T<sub>H</sub>2 and IgE responses and worsens respiratory allergic symptoms.

Slovick A, Douiri A, Muir R, Guerra A, Tsioulos K, Hay E, Lam EPS, Kelly J, Peacock JL, Ying S, Shamji MH, Cousins DJ, Durham SR, Till SJ.

J Allergy Clin Immunol. 2017 Jun;139(6):1830-1839.e13. doi: 10.1016/j.jaci.2016.09.024. Epub 2016 Oct 20.

5.

Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy.

Lawrence MG, Steinke JW, Borish L.

Ann Allergy Asthma Immunol. 2016 Aug;117(2):138-42. doi: 10.1016/j.anai.2016.06.027. Review.

6.

Allergen-specific immunotherapy in pediatric allergic asthma.

Yukselen A.

Asia Pac Allergy. 2016 Jul;6(3):139-48. doi: 10.5415/apallergy.2016.6.3.139. Epub 2016 Jul 28. Review.

7.

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis.

Okamoto Y, Fujieda S, Okano M, Yoshida Y, Kakudo S, Masuyama K.

Allergy. 2017 Mar;72(3):435-443. doi: 10.1111/all.12996. Epub 2016 Aug 23.

8.

Allergen immunotherapy in pregnancy.

Oykhman P, Kim HL, Ellis AK.

Allergy Asthma Clin Immunol. 2015 Nov 10;11:31. doi: 10.1186/s13223-015-0096-7. eCollection 2015. Review.

9.

FoxP3 Tregs Response to Sublingual Allergen Specific Immunotherapy in Children Depends on the Manifestation of Allergy.

Stelmaszczyk-Emmel A, Zawadzka-Krajewska A, Głodkowska-Mrówka E, Demkow U.

J Immunol Res. 2015;2015:731381. doi: 10.1155/2015/731381. Epub 2015 Sep 20.

10.

A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study.

Pfaar O, van Twuijver E, Boot JD, Opstelten DJ, Klimek L, van Ree R, Diamant Z, Kuna P, Panzner P.

Allergy. 2016 Jan;71(1):99-107. doi: 10.1111/all.12760. Epub 2015 Oct 26.

11.

Sublingual (SLIT) versus oral immunotherapy (OIT) for food allergy.

McGowan EC, Wood RA.

Curr Allergy Asthma Rep. 2014 Dec;14(12):486. doi: 10.1007/s11882-014-0486-9. Review.

12.

Sublingual immunotherapy as an alternative to induce protection against acute respiratory infections.

Muñoz-Wolf N, Rial A, Saavedra JM, Chabalgoity JA.

J Vis Exp. 2014 Aug 30;(90). doi: 10.3791/52036.

13.

Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses.

Viswanathan RK, Busse WW.

Chest. 2012 May;141(5):1303-1314. doi: 10.1378/chest.11-2800.

14.

Strategies of mucosal immunotherapy for allergic diseases.

Ye YL, Chuang YH, Chiang BL.

Cell Mol Immunol. 2011 Nov;8(6):453-61. doi: 10.1038/cmi.2011.17. Epub 2011 Jun 13. Review.

15.

Sublingual immunotherapy in allergic asthma: Current evidence and needs to meet.

Incorvaia C, Riario-Sforza GG, Incorvaia S, Frati F.

Ann Thorac Med. 2010 Jul;5(3):128-32. doi: 10.4103/1817-1737.65038.

16.

Development of a sublingual allergy vaccine for grass pollinosis.

Frati F, Scurati S, Puccinelli P, David M, Hilaire C, Capecce M, Marcucci F, Incorvaia C.

Drug Des Devel Ther. 2010 Jul 21;4:99-105. Review.

17.

Immunotherapy for allergies and asthma: present and future.

Mohapatra SS, Qazi M, Hellermann G.

Curr Opin Pharmacol. 2010 Jun;10(3):276-88. doi: 10.1016/j.coph.2010.05.012. Epub 2010 Jun 21. Review.

18.

T-cell responses induced by allergen-specific immunotherapy.

Maggi E.

Clin Exp Immunol. 2010 Jul 1;161(1):10-8. doi: 10.1111/j.1365-2249.2010.04148.x. Epub 2010 Apr 9. Review.

19.

Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.

de Bot CM, Moed H, Berger MY, Röder E, de Groot H, de Jongste JC, van Wijk RG, van der Wouden JC.

BMC Fam Pract. 2008 Oct 20;9:59. doi: 10.1186/1471-2296-9-59.

20.

Local nasal specific immunotherapy for allergic rhinitis.

Passalacqua G, Canonica GW.

Allergy Asthma Clin Immunol. 2006 Sep 15;2(3):117-23. doi: 10.1186/1710-1492-2-3-117. Epub 2006 Sep 15.

Supplemental Content

Loading ...
Support Center